tiprankstipranks
NurExone Gains Key EMA Status for ExoPTEN
PremiumCompany AnnouncementsNurExone Gains Key EMA Status for ExoPTEN
3M ago
NurExone Biologic Secures Funding and Expands Market Presence
Premium
Company Announcements
NurExone Biologic Secures Funding and Expands Market Presence
3M ago
NurExone’s Innovative Therapies Gain Recognition
Premium
Company Announcements
NurExone’s Innovative Therapies Gain Recognition
3M ago
NurExone Spotlights ExoPTEN Therapy at Key Conferences
PremiumCompany AnnouncementsNurExone Spotlights ExoPTEN Therapy at Key Conferences
5M ago
NurExone Biologic Advances in Exosome Production
Premium
Company Announcements
NurExone Biologic Advances in Exosome Production
6M ago
NurExone’s ExoPTEN Shows Precise Injury Targeting
Premium
Company Announcements
NurExone’s ExoPTEN Shows Precise Injury Targeting
6M ago
NurExone Targets Vision Loss with ExoPTEN Therapy
PremiumCompany AnnouncementsNurExone Targets Vision Loss with ExoPTEN Therapy
7M ago
NurExone Biologic Uplifted by Drug Development Expert
Premium
Company Announcements
NurExone Biologic Uplifted by Drug Development Expert
7M ago
NurExone Secures Japanese Patent for ExoPTEN
Premium
Company Announcements
NurExone Secures Japanese Patent for ExoPTEN
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100